Evaluation of D-18F-FMT, 18F-FDG, L- 11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice

Journal of Nuclear Medicine

Volumn 50, Issue 2, 2009, Pages 290-295

  Murayama, Chieko ^a   Harada, Norihiro ^b   Kakiuchi, Takeharu ^b   Fukumoto, Dai ^b   Kamijo, Akemi ^a   Kawaguchi, Akira T ^a   Tsukada, Hideo ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU PHOTONICS K K   (Japan)

Author keywords

18F FLT; 3 deoxy 3 18F fluorothymidine; 18F FDG; 18F fluoro 2 deoxy D glucose; D 18F FMT; L 11C methionine; L 11C MET; O 18F fluoromethyl D tyrosine; Radiation therapy

Indexed keywords

3' FLUOROTHYMIDINE F 18; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; O FLUOROMETHYL DEXTRO TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; METHIONINE; O (18F)FLUOROMETHYL L TYROSINE; O-(18F)FLUOROMETHYL-L-TYROSINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C3H MOUSE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; X IRRADIATION; ANIMAL; EVALUATION; EXPERIMENTAL NEOPLASM; METABOLISM; METHODOLOGY; PATHOLOGY; SCINTISCANNING; TUMOR CELL LINE;

ANIMALS; CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DIDEOXYNUCLEOSIDES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; METHIONINE; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; POSITRON-EMISSION TOMOGRAPHY; TYROSINE;

EID: 59249101848     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.057091     Document Type: Article

References (33)

1. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-1980.
2. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.
3. 18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-cell lymphoma model and in the human disease. Cancer Res. 2003;63:2681-2687.
4. Apisarnthanarax S, Alauddin MM, Mourtada F, et al. Early detection of chemoradioresponse in esophageal carcinoma by 3′-deoxy-3′-3H- fluorothymidine using preclinical tumor models. Clin Cancer Res. 2006;12:4590-4597.
5. Vaalburg W, Coenen HH, Crouzel C, et al. Amino acids for the measurement of protein synthesis in vivo by PET. Int J Rad Appl Instrum B. 1992;19:227-237.
6. 11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med. 1988;29:1419-1427.
7. 11C. Eur J Nucl Med. 1976;1:11-14.
8. 18F]fluoromethyl-L- tyrosine as tumor imaging tracers by PET. Nucl Med Biol. 2004;31:191-198.
9. 18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205-212.
10. 18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer. Nucl Med Biol. 2003;30:733-739.
11. 11C-methionine. J Nucl Med. 2006;47:679-688.
12. 18F-fluoropropyl tyrosine as tumour imaging agents in mice. Eur J Nucl Med Mol Imaging. 2006;33:1017-1024.
13. 18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice. J Nucl Med. 2004;45:1754-1758.
14. 18F]fluorothymidine PET to monitor early response to radiation therapy in murine SCCVII tumors. Eur J Nucl Med Mol Imaging. 2006;33:412-419.
15. 3H]thymidine, and gallium-67. J Nucl Med. 1991;32:2118-2123.
16. Van Waarde A, Been LB, Ishiwata K, Dierckx RA, Elsinga PH. Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells. J Nucl Med. 2006;47:1538-1545.
17. 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin. J Nucl Med. 2007;48:1320-1326.
18. 18F]fluoro-thymidine with 2,3′-anhydro-5′-O-(4,4′-dimethoxytrityl)-thymidine. J Labelled Comp Radiopharm. 2000;43:1211-1218.
19. 18F]fluoro-2-deoxy-D- glucose. Appl Radiat Isot. 1996;47:61-66.
20. Murayama C, Suzuki A, Sato C, et al. Radiosensitization by a new potent nucleoside analog: 1-(1′,3′,4′-trihydroxy-2′-butoxy) methyl-2-nitroimidazole(RP-343). Int J Radiat Oncol Biol Phys. 1993;26:433-443.
21. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med. 1988;29:1521-1525.
22. Furuta M, Hasegawa M, Hayakawa K, et al. Rapid rise in FDG uptake in an irradiated human tumour xenograft. Eur J Nucl Med. 1997;24:435-438.
23. Hautzel H, Muller-Gartner HW. Early changes in fluorine-18-FDG uptake during radiotherapy. J Nucl Med. 1997;38:1384-1386.
24. Shibamoto Y, Sasai K, Abe M. The radiation response of SCCVII tumor cells in C3H/He mice varies with the irradiation conditions. Radiat Res. 1987;199:352-354.
25. Murata R, Shibamoto Y, Sasai K, et al. Reoxygenation after single irradiation in rodent tumors of different types and sizes. Int J Radiat Oncol Biol Phys. 1996;34:859-865.
26. 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med. 1986;12:325-328.
27. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med. 1991;32:1485-1490.
28. Nettelbladt OS, Sundin AE, Valind SO, et al. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med. 1998;39:640-647.
29. Tsuyuguchi N, Sunada I, Ohata K, et al. Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med. 2003;17:47-51.
30. Van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med. 2006;47:150-154.
31. 18F]fluoroethyl)-L- tyrosin(FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging. 2002;29:1039-1046.
32. Oxender DL, Christensen HN. Distinct mediating system for the transport of natural amino acids by the Ehrich cell. J Biol Chem. 1963;238:3686-3699.
33. Inoue T, Tomiyoshi K, Higuchi T, et al. Biodistribution studies in L-3-[fluorine-18]fluoro-α-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med. 1998;39:663-667.